We describe an enzyme-linked immunosorbent assay (ELIsA) for urinary albumin. It requires only commercially available reagents, can detect as little as 16 zg of albumin per liter, and analytical recovery ranges from 92 to 116%. The assay is simple, rapid, and inexpensive. Albumin excretion was 6.2 (SD 4.1) mg/24 h in healthy subjects (n = 40), 14.7 (SD 7.2) mg/24 h in albumin-test-strip-negative Type I diabetics (n = 11), and 19.7 (SD 16.2) mg/24 h in patients with essential hypertension (n = 12).
Slight ("micro") albuminuria is thought to predict diabetic nephropathy in patients whose urines are albumin-negative by Albustix test strips (1) (2) (3) , but at a stage that can be reversed by sufficient metabolic control (4) (5) (6) . Once albuminuria is detectable by the Albustix test, the development of diabetic nephropathy usually can no longer be prevented. It is therefore important to have a sensitive, reliable, rapid, and inexpensive test available for urinary albumin. Exact estimation of microalbuminuria is also of special interest in control of hypertension and of patients with renal allografts Various techniques have been used for measuring microalbuminuria:
radial immunodiffusion (9, 10), immunoelectrophoresis (11), radioimmunoassays (12-16), and enzyme immunoassays (16-21). The main disadvantages of radioimmunoassays are isotope-related health and safety hazards and the short shelf-life of reagents.
Our aim in this study was to develop a sensitive, simple, and rapid immunoassay for measuring urinary albumin with use of only commercially available reagents.
Materials and Methods

Materials
Reagents. Human serum albumin was obtained from Behringwerke AG, Marburg, F.R.G. Standards.
We prepared a stock 1 mg/L solution by dissolving human serum albumin in the assay buffer; we stored aliquots at -20 #{176}C in tubes coated with the abovedescribed washing solution. From this stock solution we prepared standards containing 0.03 to 8 mg per liter, in assay buffer.
Equipment. Polystyrene microtiter plates were obtained from Nunc, Wiesbaden, F.R.G. We measured absorbance with a nliCrO-EuSA autoreader (MR 580; Dynatech, Denkendorf F.R.G.).
Samples
We collected 24-h urine specimens in polyethylene conminers that had been washed three successive times with the washing solution before use. We stored 2-mL aliquots of urine in tubes coated as described above at -20 #{176}C for not longer than two months before assay. Urine samples were centrifuged at 3700 x g and diluted 10-fold in assay buffer before assay.
Patients
Urines from all patients and apparently healthy control subjects were negative for albumin by #{176}Combur9-Test" (Boehringer Mannheim GmbH, Mannheim, F.R.G.; detection limit for albumin 60 mgfL), and for leukocytes and nitrite. Serum creatinine concentration was within the normal reference interval in all subjects, and results of routine clinical investigations were also within normal limits. Mean (±SD) age was 39.4 ± 11.2 years (range 23-55, n = 40) for the control subjects, 34.4 ± 10.4 years (range 22-48, n = 11) for Type I diabetics, and 55.0 ±7.6 years (45-66, n = 12) for patients with essential hypertension. For statistical evaluation of data we used Student's t-test.
ELISA Procedure
The ELISA was a solid-phase-binding incubate the plate for 30 mm at 20#{176}C and then empty it, tapping it while it is inverted on paper towelling. After drying, it is ready to receive urine samples. 3. Pipette 100 L of standard solution, sample, or assay buffer (as blank) into the wells in duplicate and incubate for 1.5 h at 20 #{176}C.
4. Wash the wells as described in step 2, but without the incubation step.
5. To each well add 150 pL of peroxidase-labeled goat anti-human albumin (diluted 5000-fold in assay buffer) and incubate for 1 h at 20#{176}C.
6. Wash the wells again as described in step 4. Precision. Within-run precision was measured by assaying three urine samples eight times in one assay (Table 1) . Between-run precision was estimated by assaying four urine samples on 10 consecutive days (Table 1) .
Accuracy. To check the specificity of the ELISA system, we added urea, uric acid, creatinine, and a-, -, and y.globulins to the assay buffer in their greatest physiological concentrations and assayed. No cross reactivity was detected.
Analytical recovery. Recovery of low, middle, and high (Table 2) . To demonstrate the absence of interfering substances we diluted, with assay buffer, urines having high, middle, and low concentrations of albumin (38.7, 5.0, 1.6 mgJL). The results of the dilution experiment are superimposable on the standard curve (Figure 1) .
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Albumin in 24-h urines. Using this ELISA, we measured albumin excretion in albumin-test-strip-negative Type I diabetics, in albumin-test-strip-negative patients with essential hypertension, and in control subjects (Table 3) . This excretion was significantly (p <0.05) higher in the two groups of patients than in the control subjects. We could demonstrate no correlation between urinary albumin excretion and age in either the control subjects (Table 4) or the patients.
Discussion
This enzyme iinmunoassay (double-antibody "sandwich" technique) is simple and rapid to perform; all the reagents are both commercially available and inexpensive. Inter-and intra-assay variations and analytical recovery were satisfactory, although further improvements would probably be possible if semi-automated techniques were used. The limit of detection, 16 g/L, corresponds to 1.6 ng of albumin per well, and is sufficiently low to detect above-normal albumin concentrations (5.0 ng per well in control subjects). ELISAbased urine-albumin assay techniques reported by several Others have reported conflicting results regarding agedependence of albumin excretion in healthy children (24, 25) ; we found no such correlation in adults (Table 4) .
